3 results
Approved WMOCompleted
To assess the efficacy of Mirabegron 50mg versus Solifenacin 5mg in the treatment of subjects with OAB who were dissatisfied with their treatment due to lack of efficacy.
Approved WMOCompleted
To evaluate the safety and efficacy of solifenacin succinate suspension once daily in children and adolescents with OAB.
Approved WMOCompleted
Primary Objective:To evaluate the efficacy and safety of solifenacin succinate o.d. in children and adolescents with OABSecondary Objective:To perform population pharmacokinetics after multiple-dose administration.